Good for KOLs but most of all it's good for patients.
Our original consensus platform sprang from the need for a pharmaceutical client who needed to develop consensus management guidelines for a rare disease drug quickly and cost effectively.
With input from the lead from one of our client medical communications agency, we developed the consensus platform which won an innovation award at PMEA, the pharmaceutical industry awards.
We added new functionality, and have supplied the platform to several other pharmaceutical clients who used it not only for consensus projects but also for pre work for advisory boards. To date the platform has been used by such notable organisations as Pfizer, Takeda, Merck, AbbVie, Chiesi, Horizon - the Belgian Dermatological Society and Hansa.
